Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

Clinical trial NCT06276010 · RECRUITING

Trial details

NCT number: NCT06276010
Sponsor: Xiaotong Hou
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Extracorporeal Membrane Oxygenation Complication

Start date: 2024-07-01
Primary completion: 2026-11-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.